605199.SS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 Jun 2024 @ 23:29):

Hainan Huluwa Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of drugs in the areas of Children's respiratory and digestive systems in China...

Stats
Today's Volume	1.16M
Average Volume	2.80M
Market Cap	4.34B
EPS	CNY0 ( 2024-05-22 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	45.21
ATR14	CNY0.0100 (0.09%)

Volume Correlation

Long: -0.03 (neutral)

Short: 0.44 (neutral)

Signal:(36.114) Neutral

Hainan Huluwa Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hainan Huluwa Correlation - Currency/Commodity

0.04
( neutral )

-0.02
( neutral )

0.00
( neutral )

0.67
( moderate )

0.33
( neutral )

Hainan Huluwa Financials

Annual	2023
Revenue:	CNY1.91B
Gross Profit:	CNY1.01B (52.77 %)
EPS:	CNY0.270

FY	2023
Revenue:	CNY1.91B
Gross Profit:	CNY1.01B (52.77 %)
EPS:	CNY0.270

FY	2022
Revenue:	CNY1.52B
Gross Profit:	CNY876.46M (57.85 %)
EPS:	CNY0.210

FY	2021
Revenue:	CNY1.35B
Gross Profit:	CNY808.70M (59.74 %)
EPS:	CNY0.180

Financial Reports:

No articles found.

Hainan Huluwa Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Hainan Huluwa

Hainan Huluwa Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of drugs in the areas of Children's respiratory and digestive systems in China. Its primary products include 4 grams of pediatric lung heat cough granules and capsules. The company was founded in 2005 and is based in Haikou, China.